Search results
Results from the WOW.Com Content Network
Small-cell lung carcinoma (SCLC) has long been divided into two clinicopathological stages, termed limited stage (LS) and extensive stage (ES). [8] The stage is generally determined by the presence or absence of metastases, whether or not the tumor appears limited to the thorax, and whether or not the entire tumor burden within the chest can feasibly be encompassed within a single radiotherapy ...
Continued cigarette smoking negatively impacts limited-stage small cell lung cancer survival. All clinicians and care providers should strongly encourage smoking cessation at the diagnosis of limited stage small cell lung cancer. Comparing to continued smokers, patients who quit at or after diagnosis lower the risk of death by 45%. [28]
This single cell shows the process of the central dogma of molecular biology, which are all steps researchers are interested to quantify (DNA, RNA, and Protein).. In cell biology, single-cell analysis and subcellular analysis [1] refer to the study of genomics, transcriptomics, proteomics, metabolomics, and cell–cell interactions at the level of an individual cell, as opposed to more ...
Minimal residual disease (MRD), also known as Molecular residual disease, is the name given to small numbers of cancer cells that remain in a person either during or after treatment when the patient is in remission (no symptoms or signs of disease). Sensitive molecular tests are either in development or available to test for MRD.
Cancer genome sequencing is the whole genome sequencing of a single, homogeneous or heterogeneous group of cancer cells. It is a biochemical laboratory method for the characterization and identification of the DNA or RNA sequences of cancer cell(s).
Adenocarcinoma — which starts in the cells lining the air sacs in the lungs — is the most common type of lung cancer among people who have never smoked, comprising up to 50% of diagnoses in ...
The modified T-cells were still detectable in the patients — which may point to them being able to fight any recurrence of cancer. Most neuroblastomas are diagnosed in children under 5, the ...
Carcinocythemia, also known as carcinoma cell leukemia, [2] is a condition in which cells from malignant tumours of non-hematopoietic origin are visible on the peripheral blood smear. [ 3 ] [ 4 ] It is an extremely rare condition, [ 5 ] with 33 cases identified in the literature from 1960 to 2018. [ 4 ]